曾娴婷;张春秀;肖华胜;
ZENG Xian-ting,ZHANG Chun-xiu,XIAO Hua-sheng(Shanghai Biochip Co.Ltd.,National Engineering Center for Biochip in Shanghai,Shanghai 201203,China)

• 1:上海生物芯片有限公司生物芯片上海国家工程研究中心

摘要(Abstract)：

目的对近年来出现的治疗神经痛的药物作用靶点及其机制作以综述。方法在查阅30篇文献的基础上,对神经痛的治疗靶点进行整理和归纳。结果目前治疗神经痛的药物作用靶点主要有5-羟色胺受体、去甲肾上腺素受体、阿片受体、大麻素受体、离子通道、免疫相关物质等等。以这些靶点设计的药物均已证明可在一定程度上缓解神经痛。结论为进一步开发治疗神经痛的靶向药物提供参考。
Objective To review the drug targets and their mechanisms against neuropathic pain in recent years.Methods Based on 30 references,the targets of treating neuropathic pain were classified.Results The drug targets against neuropathic pain included 5-HT receptor and nor adrenaline receptor,opiate receptor and cannabinoid receptor,ion channel,immune related substances and so on.It had been proved that the targeted medicines could relieve neuropathic pain to some degree.Conclusions The paper can provide some suggestions for drug discovery against neuropathic pain.

关键词(KeyWords)： 神经痛;受体;通道;药物
neuropathic pain;receptor;channel;drug

Abstract:

Keywords:

基金项目(Foundation): 国家“863”计划资助项目(2006AA020704);; 上海市科委资助项目(09DZ1905000)

作者(Authors): 曾娴婷;张春秀;肖华胜;
ZENG Xian-ting,ZHANG Chun-xiu,XIAO Hua-sheng(Shanghai Biochip Co.Ltd.,National Engineering Center for Biochip in Shanghai,Shanghai 201203,China)

DOI: 10.14066/j.cnki.cn21-1349/r.2010.05.012

参考文献(References)：

• [1]SINDRUP S H,JENSEN TS.Efficacy of pharmacologi-cal treatments of neuropathic pain:an update and effectrelated to mechanism of drug action[J].Pain,1999,83(3):389-400.
• [2]BRIDGES D,THOMPSON S W,RICE A S.Mecha-nisms of neuropathic pain[J].Br J Anaesth,2001,87(1):12-26.
• [3]SINDRUP S H,OTTO M,FINNERUP N B.Antide-pressants in the treatment of neuropathic pain[J].Basic Clin Pharmacol Toxicol,2005,96(6):399-409.
• [4]STANFA L,DICKENSON A,XU Xiao-juan,et al.Cho-lecystokinin and morphine analgesia:variations on atheme[J].Trends Pharmacol Sci,1994,15(3):65-66.
• [5]GUAN Yun,JOHANRK L M,HARTKE T V,et al.Pe-ripherally acting mu-opioid receptor agonist attenuatesneuropathic pain in rats after L5 spinal nerve injury[J].Pain,2008,138(2):318-329.
• [6]BENBOUZID M,GAVERIAUX-RUFF C,YALCIN I,etal.Delta-opioid receptors are critical for tricyclic anti-depressant treatment of neuropathic allodynia[J].BiolPsychiatry,2008,63(6):633-636.
• [7]HOSKING R D,ZAJICEK J P.Therapeutic potential ofcannabis in pain medicine[J].Br J Anaesth,2008,101(1):59-68.
• [8]YAMAMOTO W,MIKAMI T,IWAMURA H.In-volvement of central cannabinoid CB2receptor in re-ducing mechanical allodynia in a mouse model ofneuropathic pain[J].Eur J Pharmacol,2008,583(1):56-61.
• [9]DAVIES A,HENDRICH J,VAN MINH A T,et al.Functional biology of the alpha(2)delta subunits ofvoltage-gated calcium channels[J].Trends PharmacolSci,2007,28(5):220-228.
• [10]MARAIS E,KLUGBAUER N,HOFMANN F.Calciumchannel alpha(2)delta subunits-structure and Gabap-entin binding[J].Mol Pharmacol,2001,59(5):1243-1248.
• [11]HENDRICH J,VAN MINH A T,HEBLICH F,et al.Pharmacological disruption of calcium channel traffic-king by the alpha2delta ligand gabapentin[J].ProcNatl Acad Sci U S A,2008,105(9):3628-3633.
• [12]CUMMINS T R,RUSH A M.Voltage-gated sodiumchannel blockers for the treatment of neuropathic pain[J].Expert Rev Neurother,2007,7(11):1597-1612.
• [13]HAN Chong-yang,RUSH A M,DIB-HAJJ S D,et al.Sporadic onset of erythermalgia:a gain-of-function mu-tation in Nav1.7[J].Ann Neurol,2006,59(3):553-558.
• [14]LAI J,GOLD M S,KIM C S,et al.Inhibition of neuro-pathic pain by decreased expression of the tetrodotoxin-resistant sodium channel,Nav1.8[J].Pain,2002,95(1/2):143-152.
• [15]PASSMORE G M,SELYANKO A A,MISTRY M,etal.KCNQ/M currents in sensory neurons:significancefor pain therapy[J].J Neurosci,2003,23(18):7227-7236.
• [16]MUNRO G,DALBY-BTOWN W.Kv7(KCNQ)chan-nel modulators and neuropathic pain[J].J Med Chem,2007 50(11):2576-2582.
• [17]DUAN Bo,WU Long-jun,YU Yao-qing,et al.Upregu-lation of acid-sensing ion channel ASIC1a in spinaldorsal horn neurons contributes to inflammatory painhypersensitivity[J].J Neurosci,2007,27(41):11139-11148.
• [18]PERKINS N M,TRACEY D J.Hyperalgesia due tonerve injury:role of neutrophils[J].Neuroscience,2000,101(3):745-757.
• [19]LIU Ting-jiao,VAN ROOIJEN N,TRACEY D J.De-pletion of macrophages reduces axonal degeneration andhyperalgesia following nerve injury[J].Pain,2000,86(1/2):25-32.
• [20]ZUO Yun-xia,PERKINS N M,TRACEY D J,et al.In-flammation and hyperalgesia induced by nerve injury inthe rat:a key role of mast cells[J].Pain,2003,105(3):467-479.
• [21]WAGNER R,MYERS R R.Endoneurial injection ofTNF-alpha produces neuropathic pain behaviors[J].Neuroreport,1996,7(18):2897-2901.
• [22]SCHAFERS M,SVENSSON C I,SOMMER C,et al.Tumor necrosis factor-alpha induces mechanical allo-dynia after spinal nerve ligation by activation of p38MAPK in primary sensory neurons[J].J Neurosci,2003,23(7):2517-2521.
• [23]MIAO Pin-hui,MADEC K,GONG Yue-wen,et al.Axo-tomy-induced up-regulation of tumor necrosis factor-al-pha in the dorsal root ganglia[J].Neurol Res,2008,30(6):623-631.
• [24]ZHU Xiao-ying,CONKLIN D,EISENACH J C.Cy-clooxygenase-1 in the spinal cord plays an importantrole in postoperative pain[J].Pain,2003,104(1/2):15-23.
• [25]SUYAMA H,KAWAMOTO M,GAUS S,et al.Effect ofetodolac,a COX-2 inhibitor,on neuropathic pain in arat model[J].Brain Res,2004,1010(1/2):144-150.
• [26]SCHAFERS M,BRINKHOFF J,NEUKIRCHEN S,etal.Combined epineurial therapy with neutralizing anti-bodies to tumor necrosis factor-alpha and interleukin-1receptor has an additive effect in reducing neuropathicpain in mice[J].Neurosci Lett,2001,310(2/3):113-116.
• [27]MARCHAND F,PERRETTI M,MCMAHON S B.Roleof the immune system in chronic pain[J].Nat RevNeurosci,2005,6(7):521-532.
• [28]RAMER M S,MURPHY P G,RICHARDSON P M,etal.Spinal nerve lesion-induced mechanoallodynia andadrenergic sprouting in sensory ganglia are attenuatedin interleukin-6 knockout mice[J].Pain,1998,78(2):115-121.
• [29]JI Ru-rong,SAMAD T A,JIN Shan-xue,et al.p38MAPK activation by NGF in primary sensory neuronsafter inflammation increases TRPV1 levels and main-tains heat hyperalgesia[J].Neuron,2002,36(1):57-68.
• [30]FJELL J,CUMMINS TR,FRIED K,et al.In vivoNGFdeprivation reduces SNS expression and TTX-R sodiumcurrents in IB4-negative DRG neurons[J].J Neuro-physiol,1999,81(2):803-810.